nitroflurbiprofen has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Studies (nitroflurbiprofen) | Trials (nitroflurbiprofen) | Recent Studies (post-2010) (nitroflurbiprofen) | Studies (myelin oligodendrocyte glycoprotein (35-55)) | Trials (myelin oligodendrocyte glycoprotein (35-55)) | Recent Studies (post-2010) (myelin oligodendrocyte glycoprotein (35-55)) |
|---|---|---|---|---|---|
| 58 | 1 | 6 | 744 | 2 | 458 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergami, A; Brambilla, E; Butti, E; Comi, G; Furlan, R; Gasparini, L; Kurne, A; Martino, G; Maucci, R; Ongini, E | 1 |
1 other study(ies) available for nitroflurbiprofen and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
Topics: Administration, Oral; Adoptive Transfer; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD4-Positive T-Lymphocytes; Cell Movement; Central Nervous System; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Epitopes, T-Lymphocyte; Female; Flurbiprofen; Glycoproteins; Growth Inhibitors; Immunosuppressive Agents; Interleukin-10; Lectins, C-Type; Lymphocyte Count; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Nitric Oxide; Peptide Fragments; Receptors, Interleukin-2; RNA, Messenger; Spleen; T-Lymphocyte Subsets | 2004 |